- Home
- SBFM vs RVPH Comparison
SBFM vs RVPH Comparison
Compare SBFM & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- RVPH
- Stock Information
- Founded
- SBFM 2006
- RVPH 2006
- Country
- SBFM United States
- RVPH United States
- Employees
- SBFM N/A
- RVPH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- RVPH Health Care
- Exchange
- SBFM Nasdaq
- RVPH Nasdaq
- Market Cap
- SBFM 7.7M
- RVPH 32.8M
- IPO Year
- SBFM N/A
- RVPH N/A
- Fundamental
- Price
- SBFM $1.44
- RVPH $0.36
- Analyst Decision
- SBFM Strong Buy
- RVPH Strong Buy
- Analyst Count
- SBFM 1
- RVPH 5
- Target Price
- SBFM $15.00
- RVPH $9.00
- AVG Volume (30 Days)
- SBFM 77.5K
- RVPH 2.4M
- Earning Date
- SBFM 08-15-2025
- RVPH 08-13-2025
- Dividend Yield
- SBFM N/A
- RVPH N/A
- EPS Growth
- SBFM N/A
- RVPH N/A
- EPS
- SBFM N/A
- RVPH N/A
- Revenue
- SBFM $36,234,578.00
- RVPH N/A
- Revenue This Year
- SBFM $192.48
- RVPH N/A
- Revenue Next Year
- SBFM N/A
- RVPH N/A
- P/E Ratio
- SBFM N/A
- RVPH N/A
- Revenue Growth
- SBFM 35.51
- RVPH N/A
- 52 Week Low
- SBFM $1.17
- RVPH $0.30
- 52 Week High
- SBFM $8.78
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- SBFM 45.66
- RVPH 29.52
- Support Level
- SBFM $1.39
- RVPH $0.30
- Resistance Level
- SBFM $1.54
- RVPH $0.83
- Average True Range (ATR)
- SBFM 0.11
- RVPH 0.07
- MACD
- SBFM -0.01
- RVPH -0.04
- Stochastic Oscillator
- SBFM 9.46
- RVPH 11.25
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.